Tuberculosis Treatment Adherence of Patients in Kosovo

Overview

Journal Tuberc Res Treat

Publisher Wiley

Specialty Infectious Diseases

Date 2017 Dec 13

PMID 29230326

Citations 13

Authors

Shaip Krasniqi

Arianit Jakupi

Armond Daci

Bahri Tigani

Nora Jupolli-Krasniqi

Mimoza Pira

Valbona Zhjeqi

Burim Neziri

Affiliations

Soon will be listed here.

Abstract

Setting: The poor patient adherence in tuberculosis (TB) treatment is considered to be one of the most serious challenges which reflect the decrease of treatment success and emerging of the Multidrug Resistance-TB (MDR-TB). To our knowledge, the data about patients' adherence to anti-TB treatment in our country are missing.

Objective: This study was aimed to investigate the anti-TB treatment adherence rate and to identify factors related to eventual nonadherence among Kosovo TB patients.

Design: This study was conducted during 12 months, and the survey was a descriptive study using the standardized questionnaires with total 324 patients.

Results: The overall nonadherence for TB patient cohort was 14.5%, 95% CI (0.109-0.188). Age and place of residence are shown to have an effect on treatment adherence. Moreover, the knowledge of the treatment prognosis, daily dosage, side effects, and length of treatment also play a role. This was also reflected in knowledge regarding compliance with regular administration of TB drugs, satisfaction with the treatment, interruption of TB therapy, and the professional monitoring in the administration of TB drugs.

Conclusion: The level of nonadherence TB treatment in Kosovar patients is not satisfying, and more health care worker's commitments need to be addressed for improvement.

Citing Articles

Evaluation of health-related quality of life and adherence among pre-extensively drug-resistant tuberculosis patients receiving either Bedaquiline or Delamanid regimen at a teaching hospital in Eastern India.

Paikray E, Pattnaik M, Mishra V, Abhisek P, Pradhan S, Rout A J Family Med Prim Care. 2024; 13(10):4684-4692.

PMID: 39629384 PMC: 11610896. DOI: 10.4103/jfmpc.jfmpc_572_24.

Factors Associated with Medication Adherence in Elderly Individuals with Tuberculosis: A Qualitative Study.

Hassani S, Mohammadi Shahboulagi F, Foroughan M, Nadji S, Tabarsi P, Ghaedamini Harouni G Can J Infect Dis Med Microbiol. 2023; 2023:4056548.

PMID: 36937803 PMC: 10017217. DOI: 10.1155/2023/4056548.

Mobile application development for improving medication safety in tuberculosis patients: A quasi-experimental study protocol.

Wijayanti E, Bachtiar A, Achadi A, Rachmawati U, Sjaaf A, Eryando T PLoS One. 2022; 17(9):e0272616.

PMID: 36070321 PMC: 9451058. DOI: 10.1371/journal.pone.0272616.

Appraisal on patient compliance and factors influencing the daily regimen of anti-tubercular drugs in Mangalore city: A cross-sectional study.

Motappa R, Fathima T, Kotian H F1000Res. 2022; 11:462.

PMID: 35919097 PMC: 9296992. DOI: 10.12688/f1000research.109006.2.

Time Trend Analysis of Tuberculosis Treatment While Using Digital Adherence Technologies-An Individual Patient Data Meta-Analysis of Eleven Projects across Ten High Tuberculosis-Burden Countries.

de Groot L, Straetemans M, Maraba N, Jennings L, Gler M, Marcelo D Trop Med Infect Dis. 2022; 7(5).

PMID: 35622692 PMC: 9145978. DOI: 10.3390/tropicalmed7050065.

References

Choi H, Chung H, Muntaner C, Lee M, Kim Y, Barry C . The impact of social conditions on patient adherence to pulmonary tuberculosis treatment. Int J Tuberc Lung Dis. 2016; 20(7):948-54. PMC: 6013067. DOI: 10.5588/ijtld.15.0759. View

Kardas P, Lewek P, Matyjaszczyk M . Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013; 4:91. PMC: 3722478. DOI: 10.3389/fphar.2013.00091. View

Fagundez G, Perez-Freixo H, Eyene J, Momo J, Biye L, Esono T . Treatment Adherence of Tuberculosis Patients Attending Two Reference Units in Equatorial Guinea. PLoS One. 2016; 11(9):e0161995. PMC: 5021284. DOI: 10.1371/journal.pone.0161995. View

Tesfahuneygn G, Medhin G, Legesse M . Adherence to Anti-tuberculosis treatment and treatment outcomes among tuberculosis patients in Alamata District, northeast Ethiopia. BMC Res Notes. 2015; 8:503. PMC: 4588463. DOI: 10.1186/s13104-015-1452-x. View

Frieden T, Sbarbaro J . Promoting adherence to treatment for tuberculosis: the importance of direct observation. Bull World Health Organ. 2007; 85(5):407-9. PMC: 2636637. DOI: 10.2471/blt.06.038927. View

Hayward A, Darton T, Van-Tam J, Watson J, Coker R, Schwoebel V . Epidemiology and control of tuberculosis in Western European cities. Int J Tuberc Lung Dis. 2003; 7(8):751-7. View

Cuneo W, Snider Jr D . Enhancing patient compliance with tuberculosis therapy. Clin Chest Med. 1989; 10(3):375-80. View

Kendall E, Azman A, Cobelens F, Dowdy D . MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis. PLoS One. 2017; 12(3):e0172748. PMC: 5342197. DOI: 10.1371/journal.pone.0172748. View

Kurhasani X, Hafizi H, Toci E, Burazeri G . Tuberculosis Incidence and Case Notification Rates in Kosovo and the Balkans in 2012: Cross-country Comparison. Mater Sociomed. 2014; 26(1):55-8. PMC: 3990397. DOI: 10.5455/msm.2014.26.55-58. View

10.

Gebremariam M, Bjune G, Frich J . Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment: a qualitative study. BMC Public Health. 2010; 10:651. PMC: 2978153. DOI: 10.1186/1471-2458-10-651. View

11.

Oren E, Bell M, Garcia F, Perez-Velez C, Gerald L . Promoting adherence to treatment for latent TB infection through mobile phone text messaging: study protocol for a pilot randomized controlled trial. Pilot Feasibility Stud. 2017; 3:15. PMC: 5346839. DOI: 10.1186/s40814-017-0128-9. View

12.

Hasker E, Khodjikhanov M, Sayfiddinova S, Rasulova G, Yuldashova U, Uzakova G . Why do tuberculosis patients default in Tashkent City, Uzbekistan? A qualitative study. Int J Tuberc Lung Dis. 2010; 14(9):1132-9. View

13.

Tekle B, Mariam D, Ali A . Defaulting from DOTS and its determinants in three districts of Arsi Zone in Ethiopia. Int J Tuberc Lung Dis. 2002; 6(7):573-9. View

14.

Diwan V, Thorson A . Sex, gender, and tuberculosis. Lancet. 1999; 353(9157):1000-1. DOI: 10.1016/S0140-6736(99)01318-5. View

15.

de Vries G, van Hest N, Baars H, Sebek M, Richardus J . Factors associated with the high tuberculosis case rate in an urban area. Int J Tuberc Lung Dis. 2010; 14(7):859-65. View

16.

Volmink J, Garner P . Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2007; (4):CD003343. DOI: 10.1002/14651858.CD003343.pub3. View

17.

Dodor E, Afenyadu G . Factors associated with tuberculosis treatment default and completion at the Effia-Nkwanta Regional Hospital in Ghana. Trans R Soc Trop Med Hyg. 2005; 99(11):827-32. DOI: 10.1016/j.trstmh.2005.06.011. View

18.

Sardar P, Jha A, Roy D, Roy S, Guha P, Bandyopadhyay D . Intensive phase non-compliance to anti tubercular treatment in patients with HIV-TB coinfection: a hospital-based cross-sectional study. J Community Health. 2009; 35(5):471-8. DOI: 10.1007/s10900-009-9215-z. View

19.

Mkopi A, Range N, Lwilla F, Egwaga S, Schulze A, Geubbels E . Adherence to tuberculosis therapy among patients receiving home-based directly observed treatment: evidence from the United Republic of Tanzania. PLoS One. 2013; 7(12):e51828. PMC: 3526644. DOI: 10.1371/journal.pone.0051828. View

20.

Kulkarni P, Akarte S, Mankeshwar R, Bhawalkar J, Banerjee A, Kulkarni A . Non-adherence of new pulmonary tuberculosis patients to anti-tuberculosis treatment. Ann Med Health Sci Res. 2013; 3(1):67-74. PMC: 3634227. DOI: 10.4103/2141-9248.109507. View